Open Access
Countering emotional behaviors in the treatment of borderline personality disorder.
Author(s) -
Shan SauerZavala,
Clair Cassiello-Robbins,
Brittany K. Woods,
Andrew J. Curreri,
Juilanne Wilner Tirpak,
Madeleine Rassaby
Publication year - 2020
Publication title -
personality disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.864
H-Index - 48
eISSN - 1949-2715
pISSN - 1949-2723
DOI - 10.1037/per0000379
Subject(s) - borderline personality disorder , psychology , clinical psychology , emotional dysregulation , personality , psychotherapist , social psychology
The purpose of the current study was to investigate the unique effects of a commonly used skill incorporated into treatment packages for borderline personality disorder (BPD), countering emotion-driven behavioral urges. Individuals with BPD ( N = 8) participated in a single-case experimental design, specifically a multiple baseline, in which they were randomly assigned to complete a baseline assessment-only phase of 2 or 4 weeks. Participants then received four sessions of the countering emotional behaviors module from the unified protocol, followed by a 4-week follow-up phase. Throughout the duration of the study, daily data capture was used to assess real-time changes in the frequency of emotionally avoidant behaviors in response to emotional experiences. Symptoms of BPD, depression, and anxiety were also assessed. By follow-up, the majority of patients demonstrated a meaningful reduction (per single-case experimental design guidelines for evaluating improvements) in their use of avoidant behaviors. There was also preliminary evidence that encouraging participants to act counter to avoidant urges is associated with decreases in BPD, depression, and anxiety symptoms, as well as negative affectivity. The countering emotional behaviors skill from the unified protocol indeed engages its putative target of emotionally avoidant behavioral coping, indicating it is an active ingredient in multicomponent treatment packages for BPD, with implications for downstream clinical endpoints such as BPD and depressive and anxiety symptoms. (PsycInfo Database Record (c) 2020 APA, all rights reserved).